List view / Grid view

Retinitis pigmentosa

 

article

The evolution of cell therapy to address unmet medical needs

19 June 2024 | By ,

We had the privilege of interviewing Brian Culley, CEO of Lineage Cell Therapeutics. He discusses how Lineage’s pluripotent stem cell platform is extraordinarily advantageous, details two early-stage programmes addressing auditory and vision disorders and reveals how Lineage is choosing to target conditions that will make a real difference.